What you carry at this position in your DNA and what research says about it.
Antibiotic Hearing Loss: 9/10 evidence, 8 publications.
You're viewing every possible genotype for this variant.
None of these is your result. Use the genotype toggle to compare them, then sign up and upload your DNA to see which one is yours.
Sample genotype (not yours): A
Typical Risk of Antibiotic-Induced Hearing Loss
This maternal lineage variant is the typical version of the gene. It does not increase susceptibility to hearing damage from aminoglycoside antibiotics.
What this genotype means: Typical response to aminoglycoside antibiotics; No elevated genetic risk of mitochondrial deafness.
Sample genotype (not yours): G
High Risk of Antibiotic-Induced Hearing Loss
Carrying this maternal variant significantly increases the risk of permanent hearing loss after taking aminoglycoside antibiotics. Exposure to drugs like gentamicin can cause rapid, irreversible inner ear damage.
What this genotype means: Irreversible hearing loss after aminoglycoside exposure; Increased risk of progressive sensorineural hearing loss; Potential risk of maternally inherited cardiomyopathy.
Gene function and biological role
Gene Function: The MT-RNR1 gene encodes the mitochondrial 12S ribosomal RNA, which is essential for assembling the protein-synthesizing machinery inside mitochondria [1]. This ribosomal RNA helps translate the genetic instructions needed to produce energy-generating complexes [1]. Because mitochondria are inherited exclusively from the mother, any variants in this gene are passed down along the maternal line [2]. When this gene functions normally, it allows cells to generate energy efficiently without being vulnerable to common antibiotics [1]. However, certain changes in its structure can make the mitochondrial ribosome resemble bacterial ribosomes, creating an unintended target for specific medications [1].
Variant Impact: The rs267606617 variant, commonly known as m.1555A>G or A1555G, is a single-nucleotide change in the MT-RNR1 gene [1]. This change alters the structure of the mitochondrial 12S rRNA at the aminoacyl-tRNA acceptor site [1]. The structural alteration makes the human mitochondrial ribosome highly similar to the bacterial ribosome [1]. As a result, certain antibiotics designed to target bacteria can bind to human mitochondrial ribosomes instead, halting protein synthesis and leading to cell death in the inner ear [1] [3]. This variant is a well-known maternal genetic risk factor for permanent hearing loss [2].
Key Insight: A single dose of common antibiotics like gentamicin can trigger permanent, severe hearing loss in individuals carrying the risk variant. The risk variant makes human mitochondrial structures look almost identical to bacteria, causing antibiotics to accidentally target the inner ear.
Estimated prevalence by population
No frequency data available
This variant is not present in the gnomAD database.
Showing effects for A genotype
Organ Systems
Hearing & Balance
Antibiotic Hearing Loss. Evidence: 9/10. Source: PMID 25515069. Typical Risk.
Nonsyndromic Hearing Loss. Evidence: 9/10. Source: PMID 12920080. Typical Risk.
Pharmacogenomics
Antimicrobial & Antiviral Response
Gentamicin Toxicity. Evidence: 8/10. Source: PMID 25155176. Typical Response.
Cardiovascular & Metabolic
Heart Disease
Cardiomyopathy. Evidence: 9/10. Source: PMID 9915970. Typical Risk.
Showing effects for G genotype
Antibiotic Hearing Loss. Evidence: 9/10. Source: PMID 25515069. High Risk.
Nonsyndromic Hearing Loss. Evidence: 9/10. Source: PMID 12920080. Increased Risk.
Gentamicin Toxicity. Evidence: 8/10. Source: PMID 25155176. High Toxicity Risk.
Cardiomyopathy. Evidence: 9/10. Source: PMID 9915970. Increased Risk.
What this genotype means for the people who carry it
Sample genotype: A (Single copy)
Carrying the A allele at this mitochondrial position represents the typical genetic state found in over ninety-nine percent of the global population. Individuals with this allele do not have the structural mitochondrial ribosome changes that make them vulnerable to aminoglycoside-induced ototoxicity [1]. Standard clinical guidelines indicate a normal risk of hearing loss when exposed to medications like gentamicin or streptomycin [2]. While general medical precautions regarding antibiotic side effects still apply, there is no elevated genetic risk of sudden, permanent deafness from these drugs [1]. Additionally, this typical allele is not associated with maternally inherited nonsyndromic hearing loss or restrictive cardiomyopathy [3] [4].
Typical response to aminoglycoside antibiotics; No elevated genetic risk of mitochondrial deafness.
Sample genotype: G (Single copy)
The G allele is a well-documented mitochondrial variant that alters the 12S rRNA structure, making mitochondrial ribosomes highly sensitive to aminoglycoside antibiotics [1]. Clinical studies show that individuals carrying this variant are at extremely high risk of developing permanent, bilateral sensorineural hearing loss after receiving even a single dose of these medications [2] [3]. The hearing damage typically manifests within weeks to months following exposure [4]. Additionally, some individuals with this variant may develop progressive hearing loss over time even without antibiotic exposure [5]. In rare cases, this variant has also been linked to maternally inherited restrictive cardiomyopathy [6].
Irreversible hearing loss after aminoglycoside exposure; Increased risk of progressive sensorineural hearing loss; Potential risk of maternally inherited cardiomyopathy.
Variants with shared genetic architecture
rs267606618 · Chr M · Antibiotic Hearing Loss Risk
rs1465618 · THADA Gene · Chr 2 · Prostate Cancer Risk
rs1569419 · PRDM16 Gene · Chr 1 · Blood Cell Traits
Content updated August 2026.
ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.
Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026
Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com